Language: English

Alice in Wonderland Syndrome (ICD 10)

Alice in Wonderland syndrome (AIWS) is a rare neurological disorder characterized by distorted visual perception, alteration of body image, and an altered perception of time. These symptoms are accompanied by feelings of derealization and depersonalization.

To eat or to skip breakfast? What the science says

The majority of the purported benefits of having breakfast come from observational research, which cannot prove cause and effect. However, if a person can get their nutrients from other meals, breakfast may not be the most important meal of the day.

Long Covid now has three types

COVID-19 has 3 types of long-term effects, according to a new study. They are neurological, respiratory, and physical.

Quiet Quitting in Physicians: A Brief Overview

Quiet quitting has become a troubling trend among healthcare professionals. The term refers to workers who set hard boundaries and refuse to take on extra work, often due to pandemic-related burnout. While “quiet quitting” doesn’t mean quitting one’s job, it can have a negative effect on productivity. To address the problem, businesses should focus on employee wellness, communication, and management.

Myths surrounding migraines: 11 misconceptions

Migraine is a complex neurological disease characterized by headaches, intense throbbing pains, or pulsing sensations on one side of the head. It is the most widespread illness globally, affecting 148 million worldwide.

What Australia’s new COVID wave means

Coronavirus (COVID-19) is caused by SARS-CoV-2 virus and is an infectious disease in which infected people experience mild to moderate respiratory problems. Till November 19, the total number of COVID-19 cases in Southeast Asian countries are as follows: India: 44666676, Indonesia: 6,582,291, Malaysia: 4953418, Thailand: 4,698,373, Bangladesh: 2,036,268, Nepal: 1,000,834, Singapore: 2144522, Philippines: 4019163, Vietnam: 11509472, Bhutan: 62,460, Sri Lanka: 671,455, Myanmar: 632,865, Timor-Leste: 23,318.2

Data Privacy Notice

This Privacy Notice shall be read in conjunction with the Privacy Policy to the extent this Notice does not mention or specify the particulars that should have been mentioned or specified relating to the Notice in pursuance of the provisions of the Data Protection Laws as applicable.

On having accessed or visited this Platform you the Noticee hereby voluntarily consent to and take notice of the fact that the personal data, by which or in relation whereto you the concerned Noticee is identifiable, shall be retained, stored, used, and may be processed by the Company for the purpose and in the manner, though legal, found suitable to it for commercial and/or some other reasons. The detailed specificity whereof may be found in the Privacy Policy. The consent provided herein may be withdrawn anytime by you, the Noticee, at its own volition by removing your profile or by writing to us at support@docquity.com.

As a Noticee, you shall have the right to grievance redressal, in relation to your consent or our use of your personal data, which you may address by writing to us at dpo@docquity.com. Should you, the Noticee, thereafter remain unsatisfied or dissatisfied with the resolution provided by us, you, the Noticee, may approach the concerned regulatory authority for the redressal of your grievance.

Data Privacy Notice

By using this platform, you consent to our use of your personal data as detailed in our Privacy Policy, and acknowledge that we use cookies to improve your browsing experience